MICROBIOTIX

MicrobiotiX strives to develop treatments
 for global intractable diseases
such as multidrug-resistant
bacterial infections, autoimmune diseases and cancer

CMO SERVICE

Phage, Microbiome
& Beyond

Global Top 10 Bacteriophage Production with Optimized CMC Controls

(QbD process applied)

The GMP plant is responsible for the mass production of medicine to be used in clinical trials (phage treatments) currently under research and development. It aims to produce high-purity medicine through strict compliance and thorough quality control.


GMP

Good Manufacturing Practice

GMP embodies various conditions for manufacturing high-quality medicine and is a norm that should be observed throughout the quality management process, from the arrival of raw materials to the shipment of the final product.We aim to manufacture high-quality pharmaceuticals with high stability by eliminating human errors that may occur in the pharmaceutical manufacturing process, along with minimizing contamination through automated manufacturing facilities and strict process control.

CMC

Optimization

QbD based Bacteriophage Product characterization

Process optimization Drug substance development GMP documentation

Bacteriophage production Establishment of professional manpower


BACTERIOPHAGE
PRODUCTION
PROCESS

01

Bacteriophage
library

02

Phage culturing
after seed culturing

03

Phage concentration
after filtration

04

Removal
of endotoxin

05

Drug substance put
to refrigerated
storage

06

Automatic
vial filling

07

Manufacturing drug product
(labeling,
box packaging)


GMP

Incubation Room

30L (Fermenter) incubator
automatic sterilization system (SIP) applied

Refinery

TFF membrane (phage concentration)
IEX Chromatography (removal of Endotoxin)

Charging Room

Grade A(within the automatic vial filling machine) Production Management
10R, 10ml vial automatic filling Production CAPA: around 200,000 vials/monthly

Quality Control Laboratory

Microplate reader (Endotoxin)
Microplate reader (ELISA)
Real time PCR
Microbiology Lab (BSC)

MICROBIOTIX

Quality Assurance

The quality department of MicrobiotiX operates independently from the production department, the quality department is responsible for ensuring that all cGMP processes meet the regulatory agency’s guidelines and requirements.


Quality System

All cGMP processes are followed to adhere to all regulatory guidelines and requirements. The quality department at MicrobiotiX ensures that all systems and equipment are maintained during the cGMP production period through the quality system in place to produce high quality products.

Materials System
Production System
Packaging & Labeling System
Facilities & Equipment System
Laboratory Control System

Document System

Introduction of the document management system.
MicrobiotiX operates a document management system for the controlled creation, approval, and storage of all cGMP-related documents.

01
 Governance
02
 Policy
03
 Directive
04
 Forms and Worksheets
05
 Standard Operating Procedure

MICROBIOTIX

Quality Control

MicrobiotiX adheres to a strict quality control policies that meet global GMP regulations. We focus on delivering the highest quality products and services to our customers. This starts with ensuring high quality processes and facility operations are maintained. Our company policies are to have personal responsibility to maintain regulatory standards, promote a culture of quality compliance, and maintain world-class quality. Our leadership supports, recognizes, and rewards quality excellence. MicrobiotiX conducts risk assessments that can affect our product’s quality, stability, and/or efficacy by applying the ICH Q9 Quality Risk Management and ICH Q10 Pharmaceutical Quality System to the scientific information and data accumulated during development.

Risk assessment analysis

- Equipment
- Work environment
- Human risk

Education and document completion

Managing & determining the level of equipment

Monitoring

- Deviation
- Environmental monitoring

Product quality evaluation

- Quality standards
- Yield analysis

Improvement

- Immediate measures to prevent issues
- Quality improvement Increase productivity


Quality Management Testing Capabilities

Throughout the production process, the quality control team conducts quality tests on all samples, including raw materials, in-process, DS/DP, and stability tests. In addition, the customer has the ability to transfer testing methods and perform testing method verification in accordance with the FDA, EMA, and PMDA requirements along with the ICH Q2(R1) guidelines. MicrobiotiX maintains an optimal working environment for producing high-quality products by routinely testing facility-related samples such as environment monitoring, water and steam quality, and clean gas systems. All tests are conducted in accordance with strict cGMP requirements. In addition various tests are routinely conducted to maintain an optimal working environment for producing products. For example, environmental monitoring, testing of the purified water for injection are conducted to sustain the optimal working environment

1. Real time PCR (DNA dose)
2. Host cell Protein (ELISA)
3. Endotoxin Test

1. Sterility Test
2. Titer measurement
3. Microbial limit test

Environment
Monitoring

Consignment production
of Drug Substance (DS)
and Drug Product (DP)

MicrobiotiX complies with global regulations for the highest quality. We were also founded on the principle of delivering better CDMO services with speed and a competitive price. In line with this principle, microbiotix is trying to redefine the concept of what good customer satisfaction can be and provide the highest level of customer satisfaction, the likes of which the pharmaceutical industry has never seen before. We will provide reliable, high-quality services at all levels, from sterile filing and foreign contaminant inspection to packaging.

Aseptic filling

Small/Large commercial and clinical
vials and syringes (10R, 10ml per vial)
Bacteriophage based biological and chemical formulations

Pre-shipment
inspection
and packaging

Foreign substance inspection
Labeling and custom packaging

Quality control and storage

application of pharmaceutical quality system (ICH Q10)
Storage: refrigerated (2~4C), it is possible to store up to (-80C)

CMO SERVICE

01

We provide specialized service that includes: product development, process optimization for bacteriophage drugs developed by consigned companies, technology transfer, aseptic vial filling for the production of drugs for clinical trial and for the drugs which has gone through the clinical trials.

02

Our production capabilities and quality assurance system fully comply with Good Manufacturing Practice (cGMP) and global regulations to provide highest quality of the product.

03

MicrobiotiX is developing a treatment for intractable multidrug-resistant bacteria through bacteriophage R&D for more than 15 years. We provide consignment research and production services based on cGMP manufacturing facilities dedicated to bacteriophage and long-term R&D know-how.

MICROBIOTIX

MicrobiotiX strives to develop treatments
 for global intractable diseases
such as multidrug-resistant
bacterial infections, autoimmune diseases and cancer

CMO SERVICE

Phage, Microbiome
& Beyond

CMO SERVICE PROCEDURE


01

Service
Request Receipt

02

Consultation


03

Confidential
Disclosure
Agreement

04

Technical
consultation


05

Product request
And
Service Schedule

06

Contract
Agreement


07

Technology
Transfer

08

Production


Consulting
and Inquires 

Service applications are now available through our online platform. For inquiries, please contact microbiotix.cmo@microbiotix.net We are here to assist and will respond promptly


Tel. 82-2-6379-2649
microbiotix.cmo@microbiotix.net

Global Top 10 Bacteriophage Production
with Optimized CMC Controls (QbD process applied)

The GMP plant is responsible for the mass production of medicine to be used in clinical trials (phage treatments) currently under research and development. It aims to produce high-purity medicine through strict compliance and thorough quality control.


GMPGood Manufacturing Practice

GMP embodies various conditions for manufacturing high-quality medicine and is a norm that should be observed throughout the quality management process, from the arrival of raw materials to the shipment of the final product.We aim to manufacture high-quality pharmaceuticals with high stability by eliminating human errors that may occur in the pharmaceutical manufacturing process, along with minimizing contamination through automated manufacturing facilities and strict process control.

CMC

Optimization

QbD based Bacteriophage
Product characterization

Process optimization Drug substance development GMP documentation

Bacteriophage production Establishment of professional manpower


Bacteriophage Production Process

01

Bacteriophage
library

02

Phage culturing
after seed culturing

03

Phage concentration
after filtration

04

Removal
of endotoxin

05

Drug substance put
to refrigerated storage

06

Automatic
vial filling

07

Manufacturing drug product
(labeling, box packaging)


GMP

GMP

Incubation Room


30L (Fermenter) incubator
automatic sterilization system
(SIP) applied


GMP

Refinery


TFF membrane (phage concentration)
IEX Chromatography (removal of Endotoxin)


GMP

Charging Room


Grade A(within the automatic vial filling machine) Production Management
10R, 10ml vial automatic filling
Production CAPA: around 200,000 vials/monthly


GMP

Quality Control Laboratory


Microplate reader (Endotoxin)
Microplate reader (ELISA)
Real time PCR
Microbiology Lab (BSC)



MICROBIOTIX

Quality Assurance

The quality department of MicrobiotiX operates independently from the production department, the quality department is responsible for ensuring that all cGMP processes meet the regulatory agency’s guidelines and requirements.


Quality SystemAll cGMP processes are followed to adhere to all regulatory guidelines and requirements. The quality department at MicrobiotiX ensures that all systems and equipment are maintained during the cGMP production period through the quality system in place to produce high quality products.
Materials System
Production System
Packaging & Labeling System
Facilities & Equipment System
Laboratory Control System

Document SystemIntroduction of the document management system.
MicrobiotiX operates a document management system for the controlled creation, approval, and storage of all cGMP-related documents.
01
Governance

02
Policy

03
Directive

04

Forms and

Worksheets

05
Standard Operating Procedure


MICROBIOTIX

Quality Control

MicrobiotiX adheres to a strict quality control policies that meet global GMP regulations. We focus on delivering the highest quality products and services to our customers. This starts with ensuring high quality processes and facility operations are maintained. Our company policies are to have personal responsibility to maintain regulatory standards, promote a culture of quality compliance, and maintain world-class quality. Our leadership supports, recognizes, and rewards quality excellence. MicrobiotiX conducts risk assessments that can affect our product’s quality, stability, and/or efficacy by applying the ICH Q9 Quality Risk Management and ICH Q10 Pharmaceutical Quality System to the scientific information and data accumulated during development.

Risk
assessment
analysis

- Equipment
- Work environment
- Human risk

Education
and document
completion

Managing & determining the level of equipment

Monitoring

- Deviation
- Environmental monitoring

Improvement

- Immediate measures to prevent issues
- Quality improvement Increase productivity

Product
quality
evaluation

- Quality standards
- Yield analysis


Quality Management Testing CapabilitiesThroughout the production process, the quality control team conducts quality tests on all samples, including raw materials, in-process, DS/DP, and stability tests. In addition, the customer has the ability to transfer testing methods and perform testing method verification in accordance with the FDA, EMA, and PMDA requirements along with the ICH Q2(R1) guidelines. MicrobiotiX maintains an optimal working environment for producing high-quality products by routinely testing facility-related samples such as environment monitoring, water and steam quality, and clean gas systems. All tests are conducted in accordance with strict cGMP requirements. In addition various tests are routinely conducted to maintain an optimal working environment for producing products. For example, environmental monitoring, testing of the purified water for injection are conducted to sustain the optimal working environment

1. Real time PCR (DNA dose)
2. Host cell Protein (ELISA)
3. Endotoxin Test


1. Sterility Test
2. Titer measurement
3. Microbial limit test

Consignment production of Drug Substance (DS)
and Drug Product (DP) 

MicrobiotiX complies with global regulations for the highest quality. We were also founded on the principle of delivering better CDMO services with speed and a competitive price. In line with this principle, microbiotix is trying to redefine the concept of what good customer satisfaction can be and provide the highest level of customer satisfaction, the likes of which the pharmaceutical industry has never seen before. We will provide reliable, high-quality services at all levels, from sterile filing and foreign contaminant inspection to packaging.

Aseptic filling

Small/Large commercial and clinical
vials and syringes (10R, 10ml per vial)
Bacteriophage based biological and chemical formulations

Pre-shipment inspection
and packaging

Foreign substance inspection
Labeling and custom packaging

Quality control and storage

application of pharmaceutical quality system (ICH Q10)
Storage: refrigerated (2~4C), it is possible to store up to (-80C)

mobile background

CMO SERVICE

01

We provide specialized service that includes: product development, process optimization for bacteriophage drugs developed by consigned companies, technology transfer, aseptic vial filling for the production of drugs for clinical trial and for the drugs which has gone through the clinical trials.

02

Our production capabilities and quality assurance system fully comply with Good Manufacturing Practice (cGMP) and global regulations to provide highest quality of the product.

03

MicrobiotiX is developing a treatment for intractable multidrug-resistant bacteria through bacteriophage R&D for more than 15 years. We provide consignment research and production services based on cGMP manufacturing facilities dedicated to bacteriophage and long-term R&D know-how.

CMO SERVICE PROCEDURE

Consulting and Inquires 

Service applications are now available through our online platform. For inquiries, please contact microbiotix.cmo@microbiotix.net We are here to assist and will respond promptly

Tel. 82-2-6379-2649
microbiotix.cmo@microbiotix.net


MICROBIOTIX CO., LTD

IT Mirae Tower, 33, Digital-ro 9-gil, Geumcheon-gu, Seoul (60-21 Gasan-Dong, #304)  
TEL : 02. 6379. 2649
E-mail : mx@microbiotix.net

Copyright © MICROBIOTIX. All rights reserved.

INQUIRIES

MICROBIOTIX CO., LTD

IT Mirae Tower, 33, Digital-ro 9-gil, Geumcheon-gu, Seoul (60-21 Gasan-Dong, #304)

TEL : 02. 6379. 2649   l   E-mail : mx@microbiotix.net

Copyright © MICROBIOTIX. All rights reserved.